North America Vaccine Adjuvants Market by Manufacturers, Countries, Type and Application, Forecast to 2022

September 2017 | 121 pages | ID: N56F5B9EB4EEN
GlobalInfoResearch

Abstracts

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.

Scope of the Report:

This report focuses on the Vaccine Adjuvants in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers

• SEPPIC
• SDA BIO
• Brenntag Biosector
• SPI Pharma
• MVP Laboratories
• Tj Kaiwei
• Novavax
• Zhuoyue
• Aphios
• GSK
• CSL Limited
• Avanti Polar Lipids

Market Segment by Countries, covering

• United States
• Canada
• Mexico

Market Segment by Type, covers

• Oral
• Subcutaneous
• Intramuscular
• Others

Market Segment by Applications, can be divided into

• Adjuvants in each application, can be divided into
• Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
• Human Vaccine Adjuvants (Research Applications, Commercial Applications)

There are 15 Chapters to deeply display the North America Vaccine Adjuvants market.

Chapter 1, to describe Vaccine Adjuvants Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Vaccine Adjuvants, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Vaccine Adjuvants, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Vaccine Adjuvants market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Vaccine Adjuvants Research Findings and Conclusion, Appendix, methodology and data source

Contents

1 MARKET OVERVIEW

1.1 Vaccine Adjuvants Introduction
1.2 Market Analysis by Type
  1.2.1 Oral
  1.2.2 Subcutaneous
  1.2.3 Intramuscular
  1.2.4 Others
1.3 Market Analysis by Applications
  1.3.1 Adjuvants in each application, can be divided into
  1.3.2 Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
  1.3.3 Human Vaccine Adjuvants (Research Applications, Commercial Applications)
1.4 Market Analysis by Countries
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 Mexico Status and Prospect (2012-2022)
  1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 SEPPIC
  2.1.1 Profile
  2.1.2 Vaccine Adjuvants Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 SEPPIC Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.1.4 Business Overview
  2.1.5 SEPPIC News
2.2 SDA BIO
  2.2.1 Profile
  2.2.2 Vaccine Adjuvants Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 SDA BIO Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.2.4 Business Overview
  2.2.5 SDA BIO News
2.3 Brenntag Biosector
  2.3.1 Profile
  2.3.2 Vaccine Adjuvants Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.3.4 Business Overview
  2.3.5 Brenntag Biosector News
2.4 SPI Pharma
  2.4.1 Profile
  2.4.2 Vaccine Adjuvants Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 SPI Pharma Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.4.4 Business Overview
  2.4.5 SPI Pharma News
2.5 MVP Laboratories
  2.5.1 Profile
  2.5.2 Vaccine Adjuvants Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 MVP Laboratories Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.5.4 Business Overview
  2.5.5 MVP Laboratories News
2.6 Tj Kaiwei
  2.6.1 Profile
  2.6.2 Vaccine Adjuvants Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 Tj Kaiwei Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.6.4 Business Overview
  2.6.5 Tj Kaiwei News
2.7 Novavax
  2.7.1 Profile
  2.7.2 Vaccine Adjuvants Type and Applications
    2.7.2.1 Type
    2.7.2.2 Type
  2.7.3 Novavax Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.7.4 Business Overview
  2.7.5 Novavax News
2.8 Zhuoyue
  2.8.1 Profile
  2.8.2 Vaccine Adjuvants Type and Applications
    2.8.2.1 Type
    2.8.2.2 Type
  2.8.3 Zhuoyue Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.8.4 Business Overview
  2.8.5 Zhuoyue News
2.9 Aphios
  2.9.1 Profile
  2.9.2 Vaccine Adjuvants Type and Applications
    2.9.2.1 Type
    2.9.2.2 Type
  2.9.3 Aphios Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.9.4 Business Overview
  2.9.5 Aphios News
2.10 GSK
  2.10.1 Profile
  2.10.2 Vaccine Adjuvants Type and Applications
    2.10.2.1 Type
    2.10.2.2 Type
  2.10.3 GSK Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.10.4 Business Overview
  2.10.5 GSK News
2.11 CSL Limited
  2.11.1 Profile
  2.11.2 Vaccine Adjuvants Type and Applications
    2.11.2.1 Type
    2.11.2.2 Type
  2.11.3 CSL Limited Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.11.4 Business Overview
  2.11.5 CSL Limited News
2.12 Avanti Polar Lipids
  2.12.1 Profile
  2.12.2 Vaccine Adjuvants Type and Applications
    2.12.2.1 Type
    2.12.2.2 Type
  2.12.3 Avanti Polar Lipids Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.12.4 Business Overview
  2.12.5 Avanti Polar Lipids News

3 NORTH AMERICA VACCINE ADJUVANTS MARKET COMPETITION, BY MANUFACTURER

3.1 North America Vaccine Adjuvants Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Vaccine Adjuvants Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Vaccine Adjuvants Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Vaccine Adjuvants Manufacturer Market Share
  3.4.2 Top 5 Vaccine Adjuvants Manufacturer Market Share
3.5 Market Competition Trend

4 NORTH AMERICA VACCINE ADJUVANTS MARKET ANALYSIS BY COUNTRIES

4.1 North America Vaccine Adjuvants Sales Market Share by Countries
4.2 North America Vaccine Adjuvants Sales by Countries (2012-2017)
4.3 North America Vaccine Adjuvants Revenue (Value) by Countries (2012-2017)

5 NORTH AMERICA MARKET SEGMENTATION VACCINE ADJUVANTS BY TYPE

5.1 North America Vaccine Adjuvants Sales, Revenue and Market Share by Type (2012-2017)
  5.1.1 North America Vaccine Adjuvants Sales and Market Share by Type (2012-2017)
  5.1.2 North America Vaccine Adjuvants Revenue and Market Share by Type (2012-2017)
5.2 Oral Sales Growth and Price
  5.2.1 North America Oral Sales Growth (2012-2017)
  5.2.2 North America Oral Price (2012-2017)
5.3 Subcutaneous Sales Growth and Price
  5.3.1 North America Subcutaneous Sales Growth (2012-2017)
  5.3.2 North America Subcutaneous Price (2012-2017)
5.4 Intramuscular Sales Growth and Price
  5.4.1 North America Intramuscular Sales Growth (2012-2017)
  5.4.2 North America Intramuscular Price (2012-2017)
5.5 Others Sales Growth and Price
  5.5.1 North America Others Sales Growth (2012-2017)
  5.5.2 North America Others Price (2012-2017)

6 NORTH AMERICA MARKET SEGMENTATION VACCINE ADJUVANTS BY APPLICATION

6.1 North America Vaccine Adjuvants Sales Market Share by Application (2012-2017)
6.2 Adjuvants in each application, can be divided into Sales Growth (2012-2017)
6.3 Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications) Sales Growth (2012-2017)
6.4 Human Vaccine Adjuvants (Research Applications, Commercial Applications) Sales Growth (2012-2017)

7 UNITED STATES VACCINE ADJUVANTS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

7.1 United States Vaccine Adjuvants Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Vaccine Adjuvants Sales and Market Share by Type
7.3 United States Vaccine Adjuvants Sales by Application (2012-2017)
7.4 United States Vaccine Adjuvants Sales, Revenue and Market Share by Manufacturer
  7.4.1 United States Vaccine Adjuvants Sales and Market Share by Manufacturer
  7.4.2 United States Vaccine Adjuvants Revenue and Market Share by Manufacturer
7.5 United States Vaccine Adjuvants Export and Import (2012-2017)

8 CANADA VACCINE ADJUVANTS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

8.1 Canada Vaccine Adjuvants Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Vaccine Adjuvants Sales and Market Share by Type
8.3 Canada Vaccine Adjuvants Sales by Application (2012-2017)
8.4 Canada Vaccine Adjuvants Sales, Revenue and Market Share by Manufacturer
  8.4.1 Canada Vaccine Adjuvants Sales and Market Share by Manufacturer
  8.4.2 Canada Vaccine Adjuvants Revenue and Market Share by Manufacturer
8.5 Canada Vaccine Adjuvants Export and Import (2012-2017)

9 MEXICO VACCINE ADJUVANTS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

9.1 Mexico Vaccine Adjuvants Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Vaccine Adjuvants Sales and Market Share by Type
9.3 Mexico Vaccine Adjuvants Sales by Application (2012-2017)
9.4 Mexico Vaccine Adjuvants Sales, Revenue and Market Share by Manufacturer
  9.4.1 Mexico Vaccine Adjuvants Sales and Market Share by Manufacturer
  9.4.2 Mexico Vaccine Adjuvants Revenue and Market Share by Manufacturer
9.5 Mexico Vaccine Adjuvants Export and Import (2012-2017)

10 VACCINE ADJUVANTS MARKET FORECAST (2017-2022)

10.1 North America Vaccine Adjuvants Sales, Revenue and Growth Rate (2017-2022)
10.2 Vaccine Adjuvants Market Forecast by Countries (2017-2022)
  10.2.1 United States Vaccine Adjuvants Forecast (2017-2022)
  10.2.2 Canada Vaccine Adjuvants Forecast (2017-2022)
  10.2.3 Mexico Vaccine Adjuvants Forecast (2017-2022)
10.3 Vaccine Adjuvants Market Forecast by Type (2017-2022)
10.4 Vaccine Adjuvants Market Forecast by Application (2017-2022)

11 VACCINE ADJUVANTS MANUFACTURING COST ANALYSIS

11.1 Vaccine Adjuvants Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Vaccine Adjuvants

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Vaccine Adjuvants Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Vaccine Adjuvants Major Manufacturers in 2016
12.4 Downstream Buyers

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Vaccine Adjuvants Picture
Table Product Specifications of Vaccine Adjuvants
Figure North America Sales Market Share of Vaccine Adjuvants by Types in 2016
Table Types of Vaccine Adjuvants
Figure Oral Picture
Table Major Manufacturers of Oral
Figure Subcutaneous Picture
Table Major Manufacturers of Subcutaneous
Figure Intramuscular Picture
Table Major Manufacturers of Intramuscular
Figure Others Picture
Table Major Manufacturers of Others
Table North America Vaccine Adjuvants Sales Market Share by Applications in 2016
Table Applications of Vaccine Adjuvants
Figure Adjuvants in each application, can be divided into Picture
Figure Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications) Picture
Figure Human Vaccine Adjuvants (Research Applications, Commercial Applications) Picture
Figure United States Vaccine Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Vaccine Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Vaccine Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Table SEPPIC Basic Information, Manufacturing Base and Competitors
Table SEPPIC Vaccine Adjuvants Type and Applications
Table SEPPIC Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table SDA BIO Basic Information, Manufacturing Base and Competitors
Table SDA BIO Vaccine Adjuvants Type and Applications
Table SDA BIO Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Brenntag Biosector Basic Information, Manufacturing Base and Competitors
Table Brenntag Biosector Vaccine Adjuvants Type and Applications
Table Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table SPI Pharma Basic Information, Manufacturing Base and Competitors
Table SPI Pharma Vaccine Adjuvants Type and Applications
Table SPI Pharma Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table MVP Laboratories Basic Information, Manufacturing Base and Competitors
Table MVP Laboratories Vaccine Adjuvants Type and Applications
Table MVP Laboratories Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Tj Kaiwei Basic Information, Manufacturing Base and Competitors
Table Tj Kaiwei Vaccine Adjuvants Type and Applications
Table Tj Kaiwei Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novavax Basic Information, Manufacturing Base and Competitors
Table Novavax Vaccine Adjuvants Type and Applications
Table Novavax Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Zhuoyue Basic Information, Manufacturing Base and Competitors
Table Zhuoyue Vaccine Adjuvants Type and Applications
Table Zhuoyue Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Aphios Basic Information, Manufacturing Base and Competitors
Table Aphios Vaccine Adjuvants Type and Applications
Table Aphios Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Vaccine Adjuvants Type and Applications
Table GSK Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CSL Limited Basic Information, Manufacturing Base and Competitors
Table CSL Limited Vaccine Adjuvants Type and Applications
Table CSL Limited Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Avanti Polar Lipids Basic Information, Manufacturing Base and Competitors
Table Avanti Polar Lipids Vaccine Adjuvants Type and Applications
Table Avanti Polar Lipids Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Vaccine Adjuvants Sales by Manufacturer (2016-2017)
Figure North America Vaccine Adjuvants Sales Market Share by Manufacturer in 2016
Figure North America Vaccine Adjuvants Sales Market Share by Manufacturer in 2017
Table North America Vaccine Adjuvants Revenue by Manufacturer (2016-2017)
Figure North America Vaccine Adjuvants Revenue Market Share by Manufacturer in 2016
Figure North America Vaccine Adjuvants Revenue Market Share by Manufacturer in 2017
Table North America Vaccine Adjuvants Price by Manufacturers (2016-2017)
Figure Top 3 Vaccine Adjuvants Manufacturer Market Share in 2016
Figure Top 3 Vaccine Adjuvants Manufacturer Market Share in 2017
Figure Top 5 Vaccine Adjuvants Manufacturer Market Share in 2016
Figure Top 5 Vaccine Adjuvants Manufacturer Market Share in 2017
Figure North America Vaccine Adjuvants Sales and Growth (2012-2017)
Table North America Vaccine Adjuvants Sales by Countries (2012-2017)
Table North America Vaccine Adjuvants Sales Market Share by Countries (2012-2017)
Figure North America 2012 Vaccine Adjuvants Sales Market Share by Countries
Figure North America 2016 Vaccine Adjuvants Sales Market Share by Countries
Figure North America Vaccine Adjuvants Revenue and Growth (2012-2017)
Table North America Vaccine Adjuvants Revenue by Countries (2012-2017)
Table North America Vaccine Adjuvants Revenue Market Share by Countries (2012-2017)
Table North America 2012 Vaccine Adjuvants Revenue Market Share by Countries
Table North America 2016 Vaccine Adjuvants Revenue Market Share by Countries
Table North America Vaccine Adjuvants Sales by Type (2012-2017)
Table North America Vaccine Adjuvants Sales Share by Type (2012-2017)
Table North America Vaccine Adjuvants Revenue by Type (2012-2017)
Table North America Vaccine Adjuvants Revenue Share by Type (2012-2017)
Figure North America Oral Sales Growth (2012-2017)
Figure North America Oral Price (2012-2017)
Figure North America Subcutaneous Sales Growth (2012-2017)
Figure North America Subcutaneous Price (2012-2017)
Figure North America Intramuscular Sales Growth (2012-2017)
Figure North America Intramuscular Price (2012-2017)
Figure North America Others Sales Growth (2012-2017)
Figure North America Others Price (2012-2017)
Table North America Vaccine Adjuvants Sales by Application (2012-2017)
Table North America Vaccine Adjuvants Sales Share by Application (2012-2017)
Figure North America Adjuvants in each application, can be divided into Sales Growth (2012-2017)
Figure North America Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications) Sales Growth (2012-2017)
Figure North America Human Vaccine Adjuvants (Research Applications, Commercial Applications) Sales Growth (2012-2017)
Figure United States Vaccine Adjuvants Revenue and Growth (2012-2017)
Figure United States Vaccine Adjuvants Sales and Growth (2012-2017)
Table United States Vaccine Adjuvants Sales by Type (2012-2017)
Table United States Vaccine Adjuvants Sales Market Share by Type (2012-2017)
Table United States Vaccine Adjuvants Sales by Application (2012-2017)
Table United States Vaccine Adjuvants Sales Market Share by Application (2012-2017)
Table United States Vaccine Adjuvants Sales by Manufacturer (2016-2017)
Figure United States Vaccine Adjuvants Sales Market Share by Manufacturer in 2016
Figure United States Vaccine Adjuvants Sales Market Share by Manufacturer in 2017
Table United States Vaccine Adjuvants Revenue by Manufacturer (2016-2017)
Figure United States Vaccine Adjuvants Revenue Market Share by Manufacturer in 2016
Figure United States Vaccine Adjuvants Revenue Market Share by Manufacturer in 2017
Table United States Vaccine Adjuvants Export and Import (2012-2017)
Figure Canada Vaccine Adjuvants Revenue and Growth (2012-2017)
Figure Canada Vaccine Adjuvants Sales and Growth (2012-2017)
Table Canada Vaccine Adjuvants Sales by Type (2012-2017)
Table Canada Vaccine Adjuvants Sales Market Share by Type (2012-2017)
Table Canada Vaccine Adjuvants Sales by Application (2012-2017)
Table Canada Vaccine Adjuvants Sales Market Share by Application (2012-2017)
Table Canada Vaccine Adjuvants Sales by Manufacturer (2016-2017)
Figure Canada Vaccine Adjuvants Sales Market Share by Manufacturer in 2016
Figure Canada Vaccine Adjuvants Sales Market Share by Manufacturer in 2017
Table Canada Vaccine Adjuvants Revenue by Manufacturer (2016-2017)
Figure Canada Vaccine Adjuvants Revenue Market Share by Manufacturer in 2016
Figure Canada Vaccine Adjuvants Revenue Market Share by Manufacturer in 2017
Table Canada Vaccine Adjuvants Export and Import (2012-2017)
Figure Mexico Vaccine Adjuvants Revenue and Growth (2012-2017)
Figure Mexico Vaccine Adjuvants Sales and Growth (2012-2017)
Table Mexico Vaccine Adjuvants Sales by Type (2012-2017)
Table Mexico Vaccine Adjuvants Sales Market Share by Type (2012-2017)
Table Mexico Vaccine Adjuvants Sales by Application (2012-2017)
Table Mexico Vaccine Adjuvants Sales Market Share by Application (2012-2017)
Table Mexico Vaccine Adjuvants Sales by Manufacturer (2016-2017)
Figure Mexico Vaccine Adjuvants Sales Market Share by Manufacturer in 2016
Figure Mexico Vaccine Adjuvants Sales Market Share by Manufacturer in 2017
Table Mexico Vaccine Adjuvants Revenue by Manufacturer (2016-2017)
Figure Mexico Vaccine Adjuvants Revenue Market Share by Manufacturer in 2016
Figure Mexico Vaccine Adjuvants Revenue Market Share by Manufacturer in 2017
Table Mexico Vaccine Adjuvants Export and Import (2012-2017)
Figure North America Vaccine Adjuvants Sales, Revenue and Growth Rate (2017-2022)
Table North America Vaccine Adjuvants Sales Forecast by Countries (2017-2022)
Table North America Vaccine Adjuvants Market Share Forecast by Countries (2017-2022)
Figure United States Vaccine Adjuvants Sales Forecast (2017-2022)
Figure Canada Vaccine Adjuvants Sales Forecast (2017-2022)
Figure Mexico Vaccine Adjuvants Sales Forecast (2017-2022)
Table North America Vaccine Adjuvants Sales Forecast by Type (2017-2022)
Table North America Vaccine Adjuvants Market Share Forecast by Type (2017-2022)
Table North America Vaccine Adjuvants Sales Forecast by Application (2017-2022)
Table North America Vaccine Adjuvants Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Vaccine Adjuvants
Figure Manufacturing Process Analysis of Vaccine Adjuvants
Figure Vaccine Adjuvants Industrial Chain Analysis
Table Raw Materials Sources of Vaccine Adjuvants Major Manufacturers in 2016
Table Major Buyers of Vaccine Adjuvants
Table Distributors/Traders/ Dealers List